Citation only
via OpenAlex
Therapeutic Potential of NAD+ Precursors and Aging-related Diseases
International Journal of Biomedical Science · 2022 · ▲ 2 citations
Abstract
Nicotinamide adenine dinucleotide (NAD+) plays fundamental roles in human life and health as an essential cofactor and substrate for a great number of vital biological processes. A growing body of evidence has demonstrated that the development of many age-related degenerative diseases, including dementia, heart failure, and diabetes, are linked with an age-dependent depletion in cellular NAD+ levels. Preclinical studies have shown that the restoration of NAD+ levels through NAD+ precursors, nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) supplementation, reduces the risk of heart failure, ameliorates the manifestations of Alzheimer's and Parkinson's, and improves insulin-sensitivity in type 2 diabetes. In recent years, multiple clinical studies have indicated that NR and NMN supplements are well tolerated and effectively stimulate NAD+ metabolism in healthy subjects. Further efficacy studies of NR and NMN supplements in patients with degenerative diseases are under clinical trial. This article reviews the recent preclinical and clinical progress of NR and NMN supplements as potential therapies to treat aging-related diseases with a focus on cardiovascular disease, neurodegenerative disorders, and diabetes studies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.59566/ijbs.2022.18035
- Canonical
- link ↗
- Fetched
- 2026-10-09 MST
Cite this
APA
Gan, E. (2022). Therapeutic Potential of NAD+ Precursors and Aging-related Diseases. <em>International Journal of Biomedical Science</em>. https://doi.org/10.59566/ijbs.2022.18035
Vancouver
Gan E. Therapeutic Potential of NAD+ Precursors and Aging-related Diseases. International Journal of Biomedical Science. 2022. doi:10.59566/ijbs.2022.18035.
BibTeX
@article{estella2022Therap,
title = {Therapeutic Potential of NAD+ Precursors and Aging-related Diseases},
author = {Estella Gan},
journal = {International Journal of Biomedical Science},
year = {2022},
doi = {10.59566/ijbs.2022.18035},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Mechanisms of Ageing and Development 2021
Open access · CC-BY
Preclinical and clinical evidence of NAD+ precursors in health, disease, and ageing
Aging Medicine 2021
Open access · CC-BY
Precursor comparisons for the upregulation of nicotinamide adenine dinucleotide. Novel approaches for better aging
Food Frontiers 2024
Open access · CC-BY
An Updated Review on the Mechanisms, Pre‐Clinical and Clinical Comparisons of Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR)
Endocrine Reviews 2023
Open access · OA
Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns
Cold Spring Harbor Perspectives in Medicine 2023
Preprint · OA
Roles of NAD + in Health and Aging
Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics 2020
Open access · OA